NABTC Promotes First Brain Tumor Awareness Week

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 6 No 11
Volume 6
Issue 11

NEW YORK-The North American Brain Tumor Coalition (NABTC) kicked off the first Brain Tumor Awareness Week, October 19 to 25, 1997. The national event is designed to educate the public about the impact of brain tumors, as well as highlight the need for increased research funding.

NEW YORK—The North American Brain Tumor Coalition (NABTC) kicked off the first Brain Tumor Awareness Week, October 19 to 25, 1997. The national event is designed to educate the public about the impact of brain tumors, as well as highlight the need for increased research funding.

Said Susan Weiner, PhD, chair of the NABTC, “Our goal is to draw greater attention to a debilitating and often fatal disease for which the causes are still uncertain.” Each year, she said, approximately 100,000 people in the United States will be diagnosed with a primary or metastatic brain tumor.

To raise awareness about the need for increased research funding on Capitol Hill, the NABTC scheduled a Congressional Luncheon to take place during Brain Tumor Awareness Week.

The NABTC is also issuing a Patient Resource Guide during Brain Tumor Awareness Week to help connect brain tumor patients and their families with the various support services, informational materials, and programs provided by the coalition’s eight member organizations. A free copy can be obtained by calling 1-800-753-5877.

Recent Videos
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
Related Content